Advances and Challenges in Cancer Immunotherapy

2,081
Total downloads
13k
Total views and downloads

Articles

CASE REPORT

Published on 15 Jun 2026

Case Report: Immune checkpoint inhibitor-associated myocarditis, myositis, and myasthenia gravis overlap syndrome with flow cytometric phenotyping before and after treatment in a patient with urothelial carcinoma

Karen Gambina
Carly Tymm
Matthieu Paiola
Kurenai Tanji
John Zech
Robert Winchester
Adam Mor
Yevgeniya Gartshteyn

doi 10.3389/fimmu.2026.1793351

829 views

SYSTEMATIC REVIEW

Published on 15 Jun 2026

Efficacy, long-term survival and safety of different PD-1 inhibitors plus chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis

Wen Sun
Yansha Liu
Hui Dong
Yun Huang

doi 10.3389/fonc.2026.1849030

873 views

SYSTEMATIC REVIEW

Published on 15 May 2026

Efficacy and safety of immunotherapy in head and neck tumors: a systematic review and meta-analysis of clinical outcomes and survival benefits

Chuang Qi
Xin Zhang
Hao Guo

doi 10.3389/fonc.2026.1845660

1,216 views

SYSTEMATIC REVIEW

Published on 08 May 2026

CAR-T cell therapy in non-Hodgkin lymphoma: a clinical trial landscape review

Jinyu Wu
Yun Liao
Wen Wang
Xin Zhang

doi 10.3389/fimmu.2026.1820425

1,947 views

CASE REPORT

Published on 08 May 2026

Severe immune-related autoimmune hemolytic anemia induced by pembrolizumab: a case report with novel immunosuppressive strategy

Qin Ye
Meng Li
Ping Zhou
Shan Huang
Ke Xie

doi 10.3389/fimmu.2026.1811425

1,070 views
1 citation

CASE REPORT

Published on 23 Apr 2026

Fatal AA-like bone marrow failure and invasive pulmonary aspergillosis after long-term pembrolizumab in squamous NSCLC: a case report

Yawen Wang
Weigang Dong
Jianwen Qin

doi 10.3389/fimmu.2026.1800904

1,079 views
1 citation

CASE REPORT

Published on 22 Apr 2026

Sintilimab-induced delayed-onset toxic epidermal necrolysis in a patient with gastric carcinoma: a case report and literature review

Qiaoqiao Cheng
Shilong Mao
Liming Wang
Xiaoyan Yang
Rongrong Zhang
Li Chen
Ling Jiang
Jinyin Li
Yiping Gao
Zi Ye

doi 10.3389/fonc.2026.1752915

951 views
1 citation

ORIGINAL RESEARCH

Published on 13 Mar 2026

Meta-analysis of tuberculosis incidence and risk in cancer patients treated with immune checkpoint inhibitors

Hui Ming
Biao Fu
Xiaogang Chen
Wenbing Hu
Hui Yu

doi 10.3389/fonc.2026.1723997

792 views

ORIGINAL RESEARCH

Published on 23 Feb 2026

Harnessing SARS-CoV-2 immunity to promote antitumor responses through intratumoral vaccination and adoptive transfer

Manar Darwish
Mais Eyouni
Mohammed Yassir Yasir Khan
Rofidah Alsaggaf
Rahaf Alharbi
Haya Hawbani
Rwaa H. Abdulal
Rowa Alhabbab
Ala A. Azhari
6 more
Ahmad Bakur Bakur Mahmoud

doi 10.3389/fimmu.2026.1711569

1,278 views

REVIEW

Accepted on 02 Jul 2026

Late-Phase Strategies to Overcome Limitations of PD-1/PD-L1 Therapy: A Clinical Development Trajectory Through 2030

Elena A. Andresyuk
Natalia O. Porozova
Georgii D. Londaridze
Ivan S. Moiseev
Polina V. Kotselyabina
Yuri B. Porozov

138 views

REVIEW

Accepted on 14 Jul 2026

New Progress and Clinical Research Translation of Immune Checkpoint Inhibitors in Systemic Therapy of Gallbladder Cancer

Fuhong Li
YuXiao Wang
ZhiRen Xu
Meng Zhu
Kun Su
XiaWei Yang
Tao Wu

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Other participating journals

Frontiers in Drug Discovery
- Anti-inflammatory and Immunomodulating Agents
- 5.8 impact factor
- 5.0 citescore
Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.4 impact factor
- 6.6 citescore

Impact

13kTopic views
10kArticle views
2,081Article downloads

View impact

Articles

Case Report: Immune checkpoint inhibitor-associated myocarditis, myositis, and myasthenia gravis overlap syndrome with flow cytometric phenotyping before and after treatment in a patient with urothelial carcinoma

Efficacy, long-term survival and safety of different PD-1 inhibitors plus chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis

Efficacy and safety of immunotherapy in head and neck tumors: a systematic review and meta-analysis of clinical outcomes and survival benefits

CAR-T cell therapy in non-Hodgkin lymphoma: a clinical trial landscape review

Severe immune-related autoimmune hemolytic anemia induced by pembrolizumab: a case report with novel immunosuppressive strategy

Fatal AA-like bone marrow failure and invasive pulmonary aspergillosis after long-term pembrolizumab in squamous NSCLC: a case report

Sintilimab-induced delayed-onset toxic epidermal necrolysis in a patient with gastric carcinoma: a case report and literature review

Meta-analysis of tuberculosis incidence and risk in cancer patients treated with immune checkpoint inhibitors

Harnessing SARS-CoV-2 immunity to promote antitumor responses through intratumoral vaccination and adoptive transfer

Late-Phase Strategies to Overcome Limitations of PD-1/PD-L1 Therapy: A Clinical Development Trajectory Through 2030

New Progress and Clinical Research Translation of Immune Checkpoint Inhibitors in Systemic Therapy of Gallbladder Cancer

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Other participating journals

Frontiers in Drug Discovery

Anti-inflammatory and Immunomodulating Agents

Frontiers in Oncology

Cancer Immunity and Immunotherapy